Literature DB >> 35620272

Corrigendum to "Circulating microRNAs as Novel Potential Biomarkers for Left Ventricular Remodeling in Postinfarction Heart Failure".

Guangyuan Gao1,2, Weiwei Chen1,2, Miao Liu1,2, Xu Yan1,2, Ping Yang1,2.   

Abstract

[This corrects the article DOI: 10.1155/2019/5093803.].
Copyright © 2022 Guangyuan Gao et al.

Entities:  

Year:  2022        PMID: 35620272      PMCID: PMC9129995          DOI: 10.1155/2022/9781913

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.464


In the article titled “Circulating MicroRNAs as Novel Potential Biomarkers for Left Ventricular Remodeling in Postinfarction Heart Failure” [1], a duplication of the panels in Figure 7(b) was noted on PubPeer [2]. The authors have re-examined the data and explained that the error occurred due to the incorrect use of the ROC curve drawing software (MedCale). The authors provided the corrected ROC curve graphs and the underlying data. The corrected Figure 7(b) is shown below:
Figure 1

Expression of candidate plasma miRNAs in the patient population. (a) The expression levels of plasma miR-20a-5p, miR-340-5p, and let-7i-5p in patients with postinfarction HF (n = 32) and control patients with stable angina and without significant coronary lesions and HF (n = 16). (b) ROC curves and the AUCs of miR-20a-5p, miR-340-5p, and let-7i-5p. ∗P < 0 : 05 versus patients with stable angina and without significant coronary lesions and HF. HF: heart failure; ROC: receiver operator characteristic; AUC: area under the curve.

  1 in total

1.  Circulating MicroRNAs as Novel Potential Biomarkers for Left Ventricular Remodeling in Postinfarction Heart Failure.

Authors:  Guangyuan Gao; Weiwei Chen; Miao Liu; Xu Yan; Ping Yang
Journal:  Dis Markers       Date:  2019-12-02       Impact factor: 3.434

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.